AMAG Pharmaceuticals Announces Pricing of $175 Million of 2.50% Convertible Senior Notes Due 2019
[GlobeNewswire] – WALTHAM, Mass. — AMAG Pharmaceuticals, Inc. today announced the pricing of $175 million aggregate principal amount of 2.50% Convertible Senior Notes due 2019 (the notes) in an underwritten … more
View todays social media effects on AMAG
View the latest stocks trending across Twitter. Click to view dashboard